Volume 50 (March 2025)
Lung cancer-associated mesenchymal stem cells mediate chemoresistance and malignant progression of lung cancer through activating HIF-1α
Eur. Cell. Mater. 2025, 50, 87-108; https://doi.org/10.22203/eCM.v050a06

Intestinal stem cells (ISCs): ISCs-derived organoids for disease modeling and therapy
Eur. Cell. Mater. 2025, 50, 84-86; https://doi.org/10.22203/eCM.v050a05

A preclinical assessment of rapidly isolated chondro-progenitor cells from the infrapatellar fat pad for single-stage articular cartilage regeneration
Eur. Cell. Mater. 2025, 50, 68-83; https://doi.org/10.22203/eCM.v050a04

Hypoxia-derived mesenchymal stem-cell exosomes delivering naringin enhance osteoblast migration and fracture healing by upregulating integrin β1 via the BDNF-TrkB/ERK1/2 signaling pathway
Eur. Cell. Mater. 2025, 50, 137-151; https://doi.org/10.22203/eCM.v050a09

An analysis of predictive factors and potential mechanisms underlying lumbar disc herniation resorption
Eur. Cell. Mater. 2025, 50, 124-136; https://doi.org/10.22203/eCM.v050a08

Nano-encapsulated active protein AMPK inhibits cartilage matrix degradation in experimental osteoarthritis rats via SIRT1-regulated nexilin expression nano-AMPK inhibits cartilage matrix degradation
Eur. Cell. Mater. 2025, 50, 109-123; https://doi.org/10.22203/eCM.v050a07

Innovative immunomodulatory strategies in the management of peri-implantitis: current paradigms and future directions
Eur. Cell. Mater. 2025, 50, 33-67; https://doi.org/10.22203/eCM.v050a03

Nanocarrier-encapsulated SGLT-2 inhibitor (dapagliflozin) protects against diabetic cardiomyopathy by reducing myocardial fibrosis
Eur. Cell. Mater. 2025, 50, 20-32; https://doi.org/10.22203/eCM.v050a02

A novel intervertebral disc bioreactor system for studying clinically based active dynamic unloading combining biological and biomechanical outcomes
Eur. Cell. Mater. 2025, 50, 1-19; https://doi.org/10.22203/eCM.v050a01

Share

